Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 410

Sort by

Sort Order Select

Journal Articles

High-dose IV ascorbic acid therapy in CCUS patients with TET2 mutations

Zhuoer Xie, Jenna Fernandez, Terra L Lasho, Christy M. Finke, Michelle Amundson, Kristen McCullough, Betsy LaPlant, Abhishek A Mangaonkar, Naseema Gangat, Kaaren K Reichard, Michelle Ann Elliott, Thomas E. Witzig, Mrinal M. Patnaik

Blood blood.2024024962.

https://doi.org/10.1182/blood.2024024962

Published: 2024

Includes: Supplemental data

Journal Articles

Truncating SPEN Mutations Highlight BN2-Subtype DLBCL with Aggressive Biology and Features of Immune Evasion

Blood (2023) 142 (Supplement 1): 4140.

https://doi.org/10.1182/blood-2023-181974

Published: 2023

Journal Articles

Incidence of Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: A Retrospective Study

Izel Okcu, Jihao Zhou, Yucai Wang, Thomas M. Habermann, Thomas E. Witzig, Gita Thanarajasingam, Patrick B Johnston, Lisa M. Rimsza, Allison M. Bock, Firas Baidoun, Muhamad Alhaj Moustafa, Grzegorz S. Nowakowski

Blood (2023) 142 (Supplement 1): 6279.

https://doi.org/10.1182/blood-2023-189778

Published: 2023

Journal Articles

Cardiovascular Morbidity in Erdheim-Chester Disease (ECD) Patients with and without Cardiac Involvement

Reema K Tawfiq, Jason R Young, Madeline Mahowald, Saurabh Zanwar, Gordon J Ruan, Karen L Rech, Matthew J Koster, Lucinda Gruber, Aishwarya Ravindran, Mithun V Shah, N. Nora Bennani, Robert Vassallo, Jay Ryu, Caroline Davidge-Pitts, Surendra Dasari, Thomas E. Witzig, Ronald S. Go, Gaurav Goyal, Jithma Prasad Abeykoon

Blood (2023) 142 (Supplement 1): 4569.

https://doi.org/10.1182/blood-2023-180322

Published: 2023

Journal Articles

Lymphoid Malignancy Risk with Rare Inherited Variants in Known Cancer Predisposition Genes

Blood (2023) 142 (Supplement 1): 2990.

https://doi.org/10.1182/blood-2023-182266

Published: 2023

Journal Articles

DEK Regulates B-Cell Proliferative Capacity and Is Associated with Aggressive Disease in Low-Grade B-Cell Lymphoma

Melissa A. Hopper, Abigail R. Dropik, Janek S. Walker, Joseph P. Novak, Miranda S. Laverty, Michelle Manske, Xiaosheng Wu, Kerstin Wenzl, Jordan Edward Krull, Vivekananda Sarangi, Matthew J. Maurer, Thomas M. Habermann, Brian K. Link, Lisa M. Rimsza, Thomas E. Witzig, Stephen M Ansell, James R. Cerhan, Dragan Jevremovic, Anne J. Novak

Blood (2023) 142 (Supplement 1): 4360.

https://doi.org/10.1182/blood-2023-180232

Published: 2023

Journal Articles

Molecular Classification of Relapsed DLBCL Reveals Novel Biologic Subgroups

Blood (2023) 142 (Supplement 1): 2770.

https://doi.org/10.1182/blood-2023-180949

Published: 2023

Journal Articles

Primary Central Nervous System Lymphoma and Contemporary Clinical Prognostication

Richard C. Godby, Steven R. Hwang, Brianna Gysbers, Raphael Mwangi, Matthew J. Maurer, Thomas E. Witzig, Jonas Paludo, J. C. Villasboas, Urshila Durani, Thomas M. Habermann, Grzegorz S. Nowakowski, Arushi Khurana, Patrick B Johnston

Blood (2023) 142 (Supplement 1): 1768.

https://doi.org/10.1182/blood-2023-182866

Published: 2023

Journal Articles

The FLIPI24 Prognostic Model Identifies Poor Outcomes in Non-Immunochemotherapy Treated Patients with Follicular Lymphoma

Blood (2023) 142 (Supplement 1): 1657.

https://doi.org/10.1182/blood-2023-186684

Published: 2023

Journal Articles

Treatment Pattern and Survival Outcome of Limited Stage Mantle Cell Lymphoma: A National Cancer Database Analysis in Pre-BTK Inhibitor Vs BTK Inhibitor Era

Jihao Zhou, Jacqueline F. Wang, Steven Ray Hwang, Jonas Paludo, Javier L. Munoz, David James Inwards, Allison C. Rosenthal, William Breen, Scott Lester, Stephen M Ansell, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski, Yucai Wang

Blood (2023) 142 (Supplement 1): 1666.

https://doi.org/10.1182/blood-2023-177790

Published: 2023

Journal Articles

Phase II Study Assessing Safety and Preliminary Efficacy of High Dose Intravenous Ascorbic Acid in Patients with TET2 Mutant Clonal Cytopenias

Zhuoer Xie, Kristen McCullough, Terra L Lasho, Jenna A. Fernandez, Christy M Finke, Michelle Renee Amundson, Betsy LaPlant, Abhishek Mangaokar, Naseema Gangat, Kaaren K. Reichard, Michelle Ann Elliott, Thomas E. Witzig, Mrinal M. Patnaik

Blood (2023) 142 (Supplement 1): 4611.

https://doi.org/10.1182/blood-2023-186595

Published: 2023

Journal Articles

Effects of Antibiotic Eradication Therapy on H. Pylori -Negative Stage IE Gastric MALT Lymphoma ─ Real World Experience

Chonlada Laoruangroj, Thomas M. Habermann, Rebecca L. King, Scott Lester, Carrie Thompson, Yucai Wang, Thomas E. Witzig

Blood (2023) 142 (Supplement 1): 5157.

https://doi.org/10.1182/blood-2023-174116

Published: 2023

Journal Articles

Outcomes in Mantle Cell Lymphoma with Central Nervous System Involvement - a Dual Center Study

Blood (2023) 142 (Supplement 1): 1670.

https://doi.org/10.1182/blood-2023-174701

Published: 2023

Journal Articles

A National Cancer Database Study of Survival Trends in Patients with Mantle Cell Lymphoma Stratified By Age Group

Jacqueline F. Wang, Jihao Zhou, Steven R Hwang, Catherine S Diefenbach, Jia Ruan, Peter Martin, Jonas Paludo, Javier L. Munoz, Stephen M Ansell, Thomas E. Witzig, Thomas M. Habermann, James R. Cerhan, Grzegorz S. Nowakowski, Yucai Wang

Blood (2023) 142 (Supplement 1): 1663.

https://doi.org/10.1182/blood-2023-179611

Published: 2023

Journal Articles

Functional Testing of Variants of Uncertain Significance in TERC, TERT ,and RTEL1 from Adult Patients with Telomere Biology Disorders

Rachel A Simon, Christy M Finke, Terra L Lasho, Christopher T. Schmitz, Jenna A Fernandez, Eva M Carmona-Porquera, Mark E Wylam, Thomas E. Witzig, Tammy M McAllister, Carolyn R. Rohrer Vitek, Konstantinos N Lazaridis, Abhishek A Mangaonkar, Mrinal M. Patnaik, Alejandro Ferrer

Blood (2023) 142 (Supplement 1): 1365.

https://doi.org/10.1182/blood-2023-190153

Published: 2023

Journal Articles

Frontline Management Strategy and Quality of Life in Follicular Lymphoma: A Multi-Institutional Prospective Cohort Study

Blood (2023) 142 (Supplement 1): 3761.

https://doi.org/10.1182/blood-2023-188382

Published: 2023

Journal Articles

Artificial Intelligence Derived Changes between Baseline and Interim FDG-PET/CT Radiomics Features Are Associated with Survival Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL)

Jacob Shreve, Allison M. Bock, Izel Okcu, Antonious Hazim, Joshua C Pritchett, Raphael Mwangi, Matthew J. Maurer, Mithun V Shah, Yucai Wang, Stephen M Ansell, Thomas M. Habermann, Thomas E. Witzig, James R. Cerhan, Jason R Young, Moritz Binder, Grzegorz S. Nowakowski, Jonas Paludo

Blood (2023) 142 (Supplement 1): 5026.

https://doi.org/10.1182/blood-2023-190958

Published: 2023

Journal Articles

A First in Human Phase I Trial (LS1681) of Abraxane/Rituximab 160 Nm Nanoparticle (AR160) in Relapsed Refractory B-Cell Lymphomas Including Transformed Follicular Lymphoma: A Final Report

Thomas M. Habermann, Betsy LaPlant, Ivana Micallef, Heidi Diann Finnes, Jill Schimke, Robin Klebig, Nikki Hanley, Rebecca L. King, Thomas E. Witzig, Svetomir Markovic

Blood (2023) 142 (Supplement 1): 4471.

https://doi.org/10.1182/blood-2023-175014

Published: 2023

Journal Articles

Molecular Findings on Plasma Cell-Free DNA Analysis Among Adults with Histiocytic Neoplasms

Blood (2023) 142 (Supplement 1): 6332.

https://doi.org/10.1182/blood-2023-187500

Published: 2023

Journal Articles

Treatment Patterns and Outcomes in Relapsed/Refractory Mantle Cell Lymphoma

Blood (2022) 140 (Supplement 1): 6489–6491.

https://doi.org/10.1182/blood-2022-167633

Published: 2022

NARROW

High-dose IV ascorbic acid therapy in CCUS patients with TET2 mutations

Truncating SPEN Mutations Highlight BN2-Subtype DLBCL with Aggressive Biology and Features of Immune Evasion

Incidence of Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: A Retrospective Study

Cardiovascular Morbidity in Erdheim-Chester Disease (ECD) Patients with and without Cardiac Involvement

Lymphoid Malignancy Risk with Rare Inherited Variants in Known Cancer Predisposition Genes

DEK Regulates B-Cell Proliferative Capacity and Is Associated with Aggressive Disease in Low-Grade B-Cell Lymphoma

Molecular Classification of Relapsed DLBCL Reveals Novel Biologic Subgroups

Primary Central Nervous System Lymphoma and Contemporary Clinical Prognostication

The FLIPI24 Prognostic Model Identifies Poor Outcomes in Non-Immunochemotherapy Treated Patients with Follicular Lymphoma

Treatment Pattern and Survival Outcome of Limited Stage Mantle Cell Lymphoma: A National Cancer Database Analysis in Pre-BTK Inhibitor Vs BTK Inhibitor Era

Phase II Study Assessing Safety and Preliminary Efficacy of High Dose Intravenous Ascorbic Acid in Patients with TET2 Mutant Clonal Cytopenias

Effects of Antibiotic Eradication Therapy on H. Pylori -Negative Stage IE Gastric MALT Lymphoma ─ Real World Experience

Outcomes in Mantle Cell Lymphoma with Central Nervous System Involvement - a Dual Center Study

A National Cancer Database Study of Survival Trends in Patients with Mantle Cell Lymphoma Stratified By Age Group

Functional Testing of Variants of Uncertain Significance in TERC, TERT ,and RTEL1 from Adult Patients with Telomere Biology Disorders

Frontline Management Strategy and Quality of Life in Follicular Lymphoma: A Multi-Institutional Prospective Cohort Study

Artificial Intelligence Derived Changes between Baseline and Interim FDG-PET/CT Radiomics Features Are Associated with Survival Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL)

A First in Human Phase I Trial (LS1681) of Abraxane/Rituximab 160 Nm Nanoparticle (AR160) in Relapsed Refractory B-Cell Lymphomas Including Transformed Follicular Lymphoma: A Final Report

Molecular Findings on Plasma Cell-Free DNA Analysis Among Adults with Histiocytic Neoplasms

Treatment Patterns and Outcomes in Relapsed/Refractory Mantle Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only